Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Balancing Standardization and Innovation: Dr. Jin Li Shares Conference Highlights and the Future of AI in Clinical Research

    The “2024 CSCO Digestive Tract Tumor Standardized Treatment Workshop,” co-hosted by the Chinese Society of Clinical Oncology, Beijing Xisike Clinical Oncology Research Foundation, and Hangzhou Oriental Clinical Oncology Research Center, was held in Shanghai from August 17-18, 2024. This workshop featured diverse learning methods, including lectures, discussions, and live surgical demonstrations, aimed at improving the…

    2024.09.03
  • In-Depth Analysis of UTUC MDT Diagnosis, Radiotherapy, and Translational Development, Pioneering the Path Forward with CUDA-UTUC

    From August 8 to 11, 2024, the Annual Meeting of the Urological Surgeons Branch of the Chinese Medical Association (CUDA) was held in Xi’an. The conference was hosted by the Chinese Medical Association and the CUDA Urological Surgeons Branch, with the Air Force Medical University Xijing Hospital as the organizer and the Shaanxi Provincial Medical…

    2024.09.03
  • Hepatology丨Chinese Researchers Confirm that the EAT-Lancet Diet Significantly Reduces the Risk of Metabolic-Associated Fatty Liver Disease

    Editor’s Note With the global rise in obesity, diabetes, and metabolic syndrome, the prevalence of metabolic-associated fatty liver disease (MASLD) is also increasing. Statistics show that MASLD has become one…

    2024.09.02
  • New Strategies for Bacterial STI Prevention: The CDC Officially Incorporates Doxy PEP into Guidelines

    Editor’s Note: Recently, the U.S. Centers for Disease Control and Prevention (CDC) released an important clinical guideline offering new guidance on the prevention of bacterial sexually transmitted infections (STIs). The…

    2024.09.02
  • IDWeek丨Cutting-Edge Progress in HIV Prevention and Treatment: New Drugs and Innovative Diagnostic Technologies

    Editor’s Note: The Infectious Diseases Week (IDWeek) is a premier global academic event in the field of infectious diseases, attracting nearly ten thousand experts and scholars annually to share the…

    2024.09.01
  • Gut丨HBcrAg Levels Can Predict Chronic Hepatitis B Patients’ Response to Interferon Therapy

    Editor’s Note The current treatment options for chronic hepatitis B (CHB) primarily include long-term nucleos(t)ide analogs (NA) therapy and short-term interferon therapy. Although these approaches can control viral replication to…

    2024.09.01
  • 2024 CUDA丨Dr. Guohua Zeng: China’s Leading Role in Minimally Invasive Urological Stone Surgery, Enhancing Patient Quality of Life

    The 2024 Annual Meeting of the Urological Surgeons Branch of the Chinese Medical Association (CUDA) was held in Xi’an from August 8 to 11, 2024. The conference, organized by the Chinese Medical Association and the CUDA Urological Surgeons Branch, was hosted by the Air Force Medical University Xijing Hospital and co-organized by the Shaanxi Provincial…

    2024.08.31
  • Dr. Hailiang Zhang: Analyzing the Characteristics of Chinese UTUC Patients and Exploring Targeted Treatment Strategies to Meet the Needs of More UTUC

    Upper tract urothelial carcinoma (UTUC), which includes renal pelvis cancer and ureteral cancer, is classified alongside bladder cancer as a type of urothelial carcinoma. However, the overall incidence of UTUC is relatively low, and there are still some contentious issues in its diagnosis and treatment strategies. At the recent 2024 Annual Meeting of the Urological…

    2024.08.31
«previous next»
Recent Posts
  • Personalized mRNA Vaccine Plus Pembrolizumab Reduces Recurrence and Metastasis in Melanoma
  • ESMO Preview | Professor Huihui Li: Iza-bren Ushers in a New Era of Bispecific Antibody–Drug Conjugate Therapy for Breast Cancer
  • ESMO Preview | Professor Fan Wu: From Breakthrough to Transformation—How Iza-bren Is Reshaping Breast Cancer Treatment and Ushering in a New Era of Bispecific ADC Therapy
  • ESMO Preview | Professor Jiong Wu: China-Originated Innovation Goes Global—Izalontamab Brengitecan Ushers in a New Era of Bispecific ADC Therapy for Breast Cancer
  • 2026 Xianghu Breast Cancer Treatment Frontiers Conference | Professor Zhanhong Chen: Cardio-Oncology Supports Comprehensive Breast Cancer Care, While ADCs Reshape Treatment for Advanced HER2-Positive Disease
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top